drugset / Trial / NCT06731829
A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
RandomizedCrossoverDouble-blindDiagnostic
Summary
The purpose of this study is to evaluate the efficacy and safety of HRS-9231 for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI); to explore the effective dose of HRS-9231 for CNS MRI; and to explore the population pharmacokinetic characteristics of HRS-9231 in CNS MRI subjects
Timeline
- Start
- 2024-12
- Primary completion
- 2025-04
- Completion
- 2025-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gadobutrol | Diagnostic / imaging agent | — | — |
| Subject | HRS-9231 | Diagnostic / imaging agent | — | — |
Indications
No indication recorded.